MYND Life Sciences Inc. (CSE:MYND)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Apr 22, 2025, 5:08 PM EST
MYND Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
Cash & Equivalents | 0 | 0 | 0 | 1.9 | - | - |
Cash & Short-Term Investments | 0 | 0 | 0 | 1.9 | - | - |
Cash Growth | 188.95% | -37.62% | -99.98% | - | - | - |
Accounts Receivable | - | - | - | 0.1 | - | - |
Other Receivables | 0.61 | 0.78 | 0.13 | - | - | - |
Receivables | 0.61 | 0.78 | 0.13 | 0.1 | - | - |
Prepaid Expenses | - | 0.01 | 0.11 | 0.02 | - | - |
Other Current Assets | 0.01 | - | - | 0.03 | - | - |
Total Current Assets | 0.61 | 0.79 | 0.24 | 2.04 | - | - |
Property, Plant & Equipment | 0.01 | 0.01 | 0.12 | 0.33 | - | - |
Other Intangible Assets | - | - | - | - | 0 | - |
Other Long-Term Assets | - | - | 0.3 | 0.3 | - | - |
Total Assets | 0.72 | 0.8 | 0.65 | 2.67 | 0 | - |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
Accounts Payable | 1.24 | 1.1 | 0.71 | 0.21 | - | 0 |
Accrued Expenses | 0.44 | 0.45 | 0.22 | 0.07 | 0.05 | - |
Short-Term Debt | 3 | 3 | 2.48 | - | - | - |
Current Portion of Leases | - | - | 0.05 | 0.07 | - | - |
Other Current Liabilities | 2.03 | 1.23 | 0.67 | 0 | - | - |
Total Current Liabilities | 6.71 | 5.77 | 4.13 | 0.35 | 0.05 | 0 |
Long-Term Debt | - | - | - | 2 | - | - |
Long-Term Leases | - | - | 0.06 | 0.25 | - | - |
Long-Term Deferred Tax Liabilities | - | - | - | 0.13 | - | - |
Total Liabilities | 6.71 | 5.77 | 4.19 | 2.74 | 0.05 | 0 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
Common Stock | 3.18 | 3.18 | 3.13 | 2.6 | 0 | 0 |
Additional Paid-In Capital | 1.21 | 1.21 | 1.19 | 1.24 | - | - |
Retained Earnings | -10.52 | -9.51 | -7.99 | -4.42 | -0.06 | -0 |
Comprehensive Income & Other | 0.13 | 0.13 | 0.13 | 0.51 | - | - |
Shareholders' Equity | -5.99 | -4.98 | -3.53 | -0.07 | -0.05 | -0 |
Total Liabilities & Equity | 0.72 | 0.8 | 0.65 | 2.67 | 0 | - |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
Total Debt | 3 | 3 | 2.59 | 2.32 | - | - |
Net Cash (Debt) | -3 | -3 | -2.59 | -0.42 | - | - |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.06 | -0.06 | -0.06 | -0.01 | - | - |
Filing Date Shares Outstanding | 47.82 | 47.82 | 46.82 | 45.93 | 45.93 | 1.71 |
Total Common Shares Outstanding | 47.82 | 47.82 | 46.82 | 45.93 | 7.08 | 1.71 |
Working Capital | -6.09 | -4.98 | -3.89 | 1.69 | -0.05 | -0 |
Book Value Per Share | -0.13 | -0.10 | -0.08 | -0.00 | -0.01 | -0.00 |
Tangible Book Value | -5.99 | -4.98 | -3.53 | -0.07 | -0.05 | -0 |
Tangible Book Value Per Share | -0.13 | -0.10 | -0.08 | -0.00 | -0.01 | -0.00 |
Machinery | 0.02 | 0.02 | 0.04 | 0.04 | - | - |